️Macro Alpha Analytics
前往频道在 Telegram
欢迎加入 【Macro Alpha Analytics】 ⚖️ 法律声明 : 📌 分享性质: 本群所有观点纯属个人意见分享,不构成买卖建议 (No Buy/Sell Recommendation)。 📌 专业咨询: 在做出任何投资决定前,请务必咨询专业持牌理财顾问或您的股票经纪。 📌 责任豁免: 阁下须对自身的财务决策负全责。本群不对任何投资亏损、交易风险或决策后果承担任何法律责任。 ⚠️ 风险提示: 市场波动无常,投资需根据自身财务承受能力审慎操作。
显示更多6 444
订阅者
无数据24 小时
-307 天
-14730 天
帖子存档
80% 的投资者都觉得:股价低可以买,股价高就不能买。
但问题是▶️
股价低,不代表便宜;
股价高,也不代表贵。
关键在于:思维
不要越跌越买,除非你是巴菲特,有无限子弹。
不然你只是用有限的资金,对抗无底的下跌。
巴菲特越跌越买,是因为他有子弹打不完。
散户越跌越买,是因为不知道停手。
结果一个抄底,一个被埋底。
From UOBKH:
Hartalega Holdings (HART MK/HOLD/ RM1.37/TP:RM1.55)
1QFY26 Results Snapshot📸
🔹 Harta registered a 1QFY26 core net profit of RM8.2m (last Q: RM5.4m core losses) as revenue shrank as guided (-9.6% qoq; -5.3% yoy). This is mainly due to slower sales as US distributors frontloaded their purchase in 2H24 ahead of higher US tariffs on China gloves.
🔸 Weaker QoQ revenue reflect: i) Volume sales decline; ii) Blended ASP lower QoQ; and iii) weakening USD against RM.
🔹 1QFY26 results is deemed below expectations, only making up c.7 % of our full-year estimates. Assuming coming Qs Harta able to generate c.RM30m/Q PAT, we’ll have to revise down our FY26 earnings (RM110m ; consensus RM137m) by 10-11%. Nevertheless, we do expect improving earnings in upcoming Qs due to: i) after US tariffs on China gloves kicks-in (in terms of higher ASP and volume sales); and ii) lower input cost on cheaper raw material prices.
🔸 Our earlier rating is a HOLD with RM1.55 TP (pending review.). More details will be available after briefing later at 2.30pm.
🇲🇾 大马九家公司荣登 Forbes Asia【2025 年十亿美元以下最佳企业】榜单
Forbes Asia 刚公布【2025 年十亿美元以下最佳企业】(Best Under a Billion 2025)榜单,聚焦年营收介于 1,000 万至 10 亿美元之间、表现突出的亚太上市公司。今年共有 九家马来西亚公司上榜,包括:
Able Global Bhd
Crescendo Corp Bhd
Frontken Corp Bhd
Hibiscus Petroleum Bhd
Hup Seng Industries Bhd
ITMax System Bhd
Kerjaya Prospek Group Bhd
Pekat Group Bhd
Scientex Bhd
这份榜单评估公司成长性、盈利能力、企业治理及股东回报,是对中小市值企业竞争力的高度认可。
公司在 Q1 FY2026 营收按季下滑 RM58 百万(-9.6%)🔻 受销量减少、平均售价(ASP)下跌以及美元兑马币贬值影响,导致税前利润(PBT)降至 RM14.3 百万 🔻
Petronas in talks to sell Rio oil field stake for US$1bil | FMT
https://www.freemalaysiatoday.com/category/nation/2025/08/05/petronas-in-talks-to-sell-rio-oil-field-stake-for-us1bil
Slimmer advantage for local glove makers | The Star
https://www.thestar.com.my/business/business-news/2025/08/05/slimmer-advantage-for-local-glove-makers
After-hours movers:
Palantir (NASDAQ:PLTR) rose 4.5% after second quarter results beat estimates on the top and bottom line, and it reported strong guidance. Revenue grew 48% year-over-year and 14% quarter-over-quarter to $1.004 billion.
Hims & Hers Health (HIMS) fell 11% after reporting mixed results. Despite a bottom line beat, it reported revenue that missed estimates.
Vertex Pharma (NASDAQ:VRTX) declined 7% after it halted VX-993 development after its pain study missed the primary endpoint.
BioMarin Pharma (BMRN) rose 4.8% strong quarterly results and guidance. Revenue rose 16% year-over-year.
Kyndryl (KD) fell 7% after quarterly revenue trailed consensus estimates.
Semrush (SEMR) declined 14% after disappointing second quarter results.
Palantir Technologies Inc (NASDAQ:PLTR) stock has reached an all-time high, closing at 160.92 USD 🆕
美股三大指数在上周五下跌后,今日全面收复失地,齐齐上涨,科技股领涨大盘。「七仙女」中除了 Amazon 外,其余皆上涨,市场情绪明显回暖。
另一方面,周六公布业绩的巴菲特旗舰公司 Berkshire Hathaway 未达市场预期,股价今日下挫 3.67%。而上周暴涨 250% 的话题新股 Figma 今日遭遇回调,股价大跌 22% 🔻
截至目前,标普500指数中已有82%的公司超出盈利预期。
